Literature DB >> 26943649

Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.

Valeriya Gyurkovska1, Nina Ivanovska2.   

Abstract

INTRODUCTION: Apoptotic death of different cells observed during infection is thought to limit overwhelming inflammation in response to microbial challenge. However, the underlying apoptotic death mechanisms have not been well defined. Tumor necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein belonging to the TNF superfamily, which is involved not only in tumor growth suppression but in infection control and also in the regulation of both innate and adaptive immune responses.
FINDINGS: In this review, we have summarized data of recent studies on the influence of the TRAIL/TRAIL receptor (TRAIL-R) system on the development of viral and bacterial infections. TRAIL may have a dual function in the immune system being able to kill infected cells and also to participate in the pathogenesis of multiple infections. Moreover, many pathogens have evolved mechanisms to manipulate TRAIL signaling thus increasing pathogen replication.
CONCLUSION: Present data highlight an essential role for the TRAIL/TRAIL-R system in the regulation and modulation of apoptosis and show that TRAIL has distinct roles in pathogenesis and pathogen elimination. Knowledge of the factors that determine whether TRAIL is helpful or harmful supposes its potential therapeutic implications that are only beginning to be explored.

Entities:  

Keywords:  Bacterial infections; TRAIL; TRAIL-deficient mice; Viral infections

Mesh:

Substances:

Year:  2016        PMID: 26943649     DOI: 10.1007/s00011-016-0934-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  107 in total

1.  NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.

Authors:  Andreas Glässner; Marianne Eisenhardt; Benjamin Krämer; Christian Körner; Martin Coenen; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

2.  IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

Authors:  L M Sedger; D M Shows; R A Blanton; J J Peschon; R G Goodwin; D Cosman; S R Wiley
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

3.  Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.

Authors:  M Leverkus; M Neumann; T Mengling; C T Rauch; E B Bröcker; P H Krammer; H Walczak
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

4.  Apoptosis enhancement by the HIV-1 Nef protein.

Authors:  A Rasola; D Gramaglia; C Boccaccio; P M Comoglio
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

5.  CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Authors:  Edith M Janssen; Nathalie M Droin; Edward E Lemmens; Michael J Pinkoski; Steven J Bensinger; Benjamin D Ehst; Thomas S Griffith; Douglas R Green; Stephen P Schoenberger
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

Review 6.  Following TRAIL's path in the immune system.

Authors:  Christina Falschlehner; Uta Schaefer; Henning Walczak
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

7.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

8.  Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

Authors:  T S Griffith; S R Wiley; M Z Kubin; L M Sedger; C R Maliszewski; N A Fanger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

9.  Staphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts.

Authors:  Emily H Alexander; F Andrea Rivera; Ian Marriott; Juan Anguita; Kenneth L Bost; Michael C Hudson
Journal:  BMC Microbiol       Date:  2003-04-02       Impact factor: 3.605

10.  Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

Authors:  Maria A Stacey; Morgan Marsden; Tu Anh Pham N; Simon Clare; Garry Dolton; Gabrielle Stack; Emma Jones; Paul Klenerman; Awen M Gallimore; Philip R Taylor; Robert J Snelgrove; Trevor D Lawley; Gordon Dougan; Chris A Benedict; Simon A Jones; Gavin W G Wilkinson; Ian R Humphreys
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

View more
  16 in total

1.  Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.

Authors:  Gaelle Picarda; Raima Ghosh; Bryan McDonald; Shilpi Verma; Nicolas Thiault; Rachid El Morabiti; Thomas S Griffith; Chris A Benedict
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

2.  An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Hsiu-Jung Liao; Chien-Sheng Wu; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2017-04-10       Impact factor: 11.530

3.  TNF-α Triggers RIP1/FADD/Caspase-8-Mediated Apoptosis of Astrocytes and RIP3/MLKL-Mediated Necroptosis of Neurons Induced by Angiostrongylus cantonensis Infection.

Authors:  Hongli Zhou; Minyu Zhou; Yue Hu; Yanin Limpanon; Yubin Ma; Ping Huang; Paron Dekumyoy; Wanchai Maleewong; Zhiyue Lv
Journal:  Cell Mol Neurobiol       Date:  2021-03-08       Impact factor: 4.231

4.  Inducement of apoptosis by cucurbitacin E, a tetracyclic triterpenes, through death receptor 5 in human cervical cancer cell lines.

Authors:  Ya-Min Cheng; Ching-Ju Shen; Chi-Chang Chang; Cheng-Yang Chou; Ching-Chou Tsai; Yi-Chiang Hsu
Journal:  Cell Death Discov       Date:  2017-04-24

Review 5.  Biomarkers in Pediatric Community-Acquired Pneumonia.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-19       Impact factor: 5.923

6.  Comparative Genomics of Sibling Species of Fonsecaea Associated with Human Chromoblastomycosis.

Authors:  Vania A Vicente; Vinícius A Weiss; Amanda Bombassaro; Leandro F Moreno; Flávia F Costa; Roberto T Raittz; Aniele C Leão; Renata R Gomes; Anamelia L Bocca; Gheniffer Fornari; Raffael J A de Castro; Jiufeng Sun; Helisson Faoro; Michelle Z Tadra-Sfeir; Valter Baura; Eduardo Balsanelli; Sandro R Almeida; Suelen S Dos Santos; Marcus de Melo Teixeira; Maria S Soares Felipe; Mariana Machado Fidelis do Nascimento; Fabio O Pedrosa; Maria B Steffens; Derlene Attili-Angelis; Mohammad J Najafzadeh; Flávio Queiroz-Telles; Emanuel M Souza; Sybren De Hoog
Journal:  Front Microbiol       Date:  2017-10-09       Impact factor: 5.640

Review 7.  The Interleukin-10 Family of Cytokines and Their Role in the CNS.

Authors:  Amanda R Burmeister; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2018-11-27       Impact factor: 5.505

Review 8.  The Role of Osteoprotegerin and Its Ligands in Vascular Function.

Authors:  Luc Rochette; Alexandre Meloux; Eve Rigal; Marianne Zeller; Yves Cottin; Catherine Vergely
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

Review 9.  Biomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management.

Authors:  Elena N Savvateeva; Alla Yu Rubina; Dmitry A Gryadunov
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

Review 10.  The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.

Authors:  Christin Peteranderl; Susanne Herold
Journal:  Front Immunol       Date:  2017-03-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.